Dr. Kanika Singroha

Founder & CEO

Cellverse is more than a company it's a movement to reimagine human health from the inside out. Our vision is a world where new treatments are tested on living human biology instead of animal trials, where every patient's care is guided by their own digital twin, and where MedTech innovation is built on transparent governance. Through three converging platforms – an in vitro human disease model that moves beyond animal testing, digital twin technology for personalised medicine, and a MedTech governance platform – we are building a future rooted in the philosophy of One Health: one health for humans, animals and the planet, together. Cellverse is the result of a doctoral journey that refused to end on paper. Dr. Kanika Singroha, a trained maxillofacial pathologist and India–Stanford Biodesign Fellow (2023–24), pursued her PhD in Bio-fabrication at IIT–AIIMS Jodhpur with one defining belief: that research shouldn't gather dust in a thesis, it should walk into the world and heal. That belief gave birth to Cellverse – the living embodiment of years at the bench, translated into real-world medtech solutions.